BackMylan N.V. Overview

Mylan N.V. Total Assets

Track Mylan N.V.'s total assets ($31B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$31.24B
↑ 0.61% YoYΔ $189.60M vs prior year quarter

Peer trimmed avg / median

Loading

Mylan N.V. Total Assets History

Loading

Mylan N.V. vs. peers: Total Assets Comparison

Loading

Mylan N.V. Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Mylan N.V. (MYL) FAQ

Mylan N.V. (MYL) currently reports a total assets of $31B as of September 2020. That compares with $31B in the prior-year period — up 0.6% year over year. Use the charts on this page to explore Mylan N.V.'s total assets history and peer comparisons.

Mylan N.V.'s total assets increased from $31B to $31B — a 0.6% year-over-year increase (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mylan N.V. reported $31B in total assets as of September 2020. That compares with $31B in the prior-year period — up 0.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $31B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mylan N.V., and consider following MYL for alerts when major investors trade the stock.

Mylan N.V. is classified in the Healthcare sector. On total assets, it currently shows $31B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MYL with unrelated industries.